Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
Guan-Hua Su(Fudan University Shanghai Cancer Center), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University), J Zhou(Fudan University Shanghai Cancer Center), Yajia Gu(Fudan University Shanghai Cancer Center), Shiyun Sun(Fudan University Shanghai Cancer Center), Shen Zhao(Fudan University Shanghai Cancer Center), He Wang(Shanghai Center for Brain Science and Brain-Inspired Technology), Chao You(Fudan University Shanghai Cancer Center), Yi Xiao(Fudan University Shanghai Cancer Center), Zhi‐Ming Shao(Shanghai Medical College of Fudan University), Luyi Lin(Fudan University Shanghai Cancer Center), Rencheng Zheng(Shanghai Center for Brain Science and Brain-Inspired Technology)
Cited by 114
Related Papers
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171
Radiomics in breast cancer: Current advances and future directions
|Cell Reports Medicine|2024|143